| 1 |
surface-enhanced laser desorption/ionization
(174 times)
|
Neoplasms
(24 times)
|
MS (16 times)
TOF (15 times)
MALDI (6 times)
|
1998 Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry.
|
| 2 |
surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
(12 times)
|
Neoplasms
(4 times)
|
AFP (1 time)
ED (1 time)
ELISA (1 time)
|
2000 An internal histidine residue from the bacterial surface protein, PAM, mediates its binding to the kringle-2 domain of human plasminogen.
|
| 3 |
surface-enhanced laser desorption/ionization mass spectrometry
(5 times)
|
Biochemistry
(2 times)
|
ELISA (2 times)
AD (1 time)
BUD (1 time)
|
2002 Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications.
|
| 4 |
Surface Enhanced Laser Desorption Ionisation-ProteinChip
(2 times)
|
Microbiology
(1 time)
|
APP (1 time)
BHI (1 time)
|
2004 Analysis of differential protein expression in Actinobacillus pleuropneumoniae by Surface Enhanced Laser Desorption Ionisation--ProteinChip (SELDI) technology.
|
| 5 |
Surface Enhanced Laser Desorption/Ionization technique
(1 time)
|
Proteomics
(1 time)
|
UREA-CHAPS (1 time)
|
2006 Optimising the use of TRIzol-extracted proteins in surface enhanced laser desorption/ ionization (SELDI) analysis.
|
| 6 |
surface-enhanced laser desorption
(1 time)
|
Chemistry, Clinical
(1 time)
|
TOFMS (1 time)
|
2005 Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
|
| 7 |
surface-enhanced laser desorption ionization/time of flight
(1 time)
|
Neoplasms
(1 time)
|
KNN (1 time)
|
2009 Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.
|
A Search Service for Abbreviation / Long Form